| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $308.1M | +37.2% |
| Cost of Revenue | $111.8M | +28.0% |
| Gross Profit | $196.2M | +43.1% |
| R&D Expense | $71.3M | +14.4% |
| SG&A Expense | $228.8M | +33.5% |
| Operating Income | -$103.9M | -7.5% |
| Pre-tax Income | -$95.4M | -4.8% |
| Income Tax | $190K | — |
| Net Income | -$95.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $286.5M | -14.1% |
| Accounts Receivable | $83.5M | +0.0% |
| Inventory | $70.7M | +25.9% |
| Current Assets | $450.4M | -6.5% |
| Total Assets | $508.1M | -4.9% |
| Current Liabilities | $65.8M | +23.8% |
| Long-term Debt | $51.6M | +0.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.0M | +50.6% |
| Capital Expenditures | $9.4M | +112.2% |
| Investing Cash Flow | -$9.4M | -112.2% |
| Financing Cash Flow | $11.2M | -93.8% |
| Free Cash Flow | -$58.3M | +43.7% |
| -4.5% |
| EPS (Basic) | -$1.72 | +1.7% |
| EPS (Diluted) | -$1.72 | +1.7% |
| Total Liabilities |
| $142.2M |
| +7.9% |
| Stockholders' Equity | $365.9M | -9.0% |